NITO Stock - N2OFF, Inc.
Unlock GoAI Insights for NITO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $210,000 | $263,445 | $394,004 | $438,141 | $232,274 |
| Gross Profit | $45,000 | $208,267 | $235,691 | $302,198 | $188,869 |
| Gross Margin | 21.4% | 79.1% | 59.8% | 69.0% | 81.3% |
| Operating Income | $-4,320,000 | $-7,577,776 | $-5,819,642 | $-4,703,639 | $-1,349,345 |
| Net Income | $-5,193,000 | $-6,522,408 | $-5,739,600 | $-4,820,580 | $-1,593,139 |
| Net Margin | -2472.9% | -2475.8% | -1456.7% | -1100.2% | -685.9% |
| EPS | $-31.15 | $-190.05 | $-379.75 | $-504.00 | $-256.90 |
N2OFF, Inc., an agri-food tech company, develops and sells eco-friendly green treatments for the food industry to enhance food safety and shelf life of fresh produce. The company's products are based on proprietary blend of food acids combined with oxidizing agent-based sanitizers for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. Its products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. The company also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.
Visit WebsiteEarnings History & Surprises
NITOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-8.29 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-6.29 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.39 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.24 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.39 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.23 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.26 | — | — |
Q1 2024 | Mar 25, 2024 | — | $-1.75 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-1.78 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.71 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-2.57 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-2.11 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-3.33 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-3.07 | — | — |
Q1 2022 | Mar 30, 2022 | — | $-3.30 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-3.89 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-3.23 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-4.80 | — | — |
Latest News
N2OFF Closes Merger With MitoCareX Bio, Expanding Into Cancer Drug Discovery Targeting The Mitochondrial SLC25 Protein Family
📈 PositiveN2OFF Regains Nasdaq Compliance
📈 PositiveSciSparc shares are trading higher after the company announced that N2OFF stockholders voted and approved the proposed acquisition of SciSparc's majority owned subsidiary, MitoCareX Bio.
📈 PositiveSciSparc shares are trading higher after the company announced that N2OFF stockholders voted and approved the proposed acquisition of SciSparc's majority owned subsidiary, MitoCareX Bio.
📈 PositiveSciSparc's subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29%
📈 PositiveN2OFF Receives Shareholders Approval For Merger With SciSparc's Majority Owned Subsidiary MitoCareX
📈 PositiveMarket-Moving News for September 26th
➖ NeutralNITO stock has given up its prior gain. N2OFF shares were trading higher after stockholders approved the acquisition of MitoCareX Bio.
➖ NeutralN2OFF shares are trading higher after stockholders approved the acquisition of MitoCareX Bio.
📈 PositiveN2OFF Stockholders Approve Acquisition Of Cancer Drug Discovery Firm MitoCareX Bio For $700K Cash And 40% Of The Company's Fully Diluted Capital Stock
📈 PositiveTrading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
➖ NeutralN2OFF shares are trading lower after the company announced a 1-for-35 reverse stock split.
📉 NegativeN2OFF to execute 1-for-35 reverse stock split
📉 NegativeN2OFF Announces A 1-For-35 Reverse Stock Split Of Its Common Stock, Effective September 22, 2025
📉 NegativeN2OFF Advances Global Clean Energy Transition With Solar and Storage Initiatives In Germany, Italy, And Poland Via Solterra Partnership
📈 PositiveN2OFF Commits €600,000 To Melz Battery Storage Study Under Expanded Loan Agreement; Approves 1-for-35 Reverse Stock Split
➖ NeutralN2OFF via Solterra expands European footprint with entry into fourth project; shares rise
📈 PositiveFrequently Asked Questions about NITO
What is NITO's current stock price?
What is the analyst price target for NITO?
What sector is N2OFF, Inc. in?
What is NITO's market cap?
Does NITO pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to NITO for comparison